136 related articles for article (PubMed ID: 22173049)
1. Skin metastases in non-small cell lung cancer.
Bobba RK; Odem JL; Doll DC; Perry MC
Am J Med Sci; 2012 Jul; 344(1):59-62. PubMed ID: 22173049
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy for advanced stage non-small cell lung cancer.
Fathi AT; Brahmer JR
Semin Thorac Cardiovasc Surg; 2008; 20(3):210-6. PubMed ID: 19038730
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous metastases from non-small cell lung cancer.
Alkhayat H; Hong CH
J Cutan Med Surg; 2006; 10(6):304-7. PubMed ID: 17241601
[TBL] [Abstract][Full Text] [Related]
4. Skin metastases from lung cancer.
Mollet TW; Garcia CA; Koester G
Dermatol Online J; 2009 May; 15(5):1. PubMed ID: 19624979
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, non-small-cell lung cancer with poor prognosis (TITAN): a randomised multicentre, open-label, phase 3 study.
Ciuleanu T; Stelmakh L; Cicenas S; Miliauskas S; Grigorescu AC; Hillenbach C; Johannsdottir HK; Klughammer B; Gonzalez EE
Lancet Oncol; 2012 Mar; 13(3):300-8. PubMed ID: 22277837
[TBL] [Abstract][Full Text] [Related]
6. Scalp metastases--an unusual presentation of non-small cell lung cancer prognosis of cutaneous metastases in the current era.
Rachakonda KM; George MK; Peek RD
J Cancer Res Ther; 2013; 9(1):145-7. PubMed ID: 23575099
[TBL] [Abstract][Full Text] [Related]
7. Safety of bevacizumab in patients with non-small-cell lung cancer and brain metastases.
Socinski MA; Langer CJ; Huang JE; Kolb MM; Compton P; Wang L; Akerley W
J Clin Oncol; 2009 Nov; 27(31):5255-61. PubMed ID: 19738122
[TBL] [Abstract][Full Text] [Related]
8. Platinum-Vinorelbine Induction Chemotherapy plus Bevacizumab With and Without Pemetrexed Switch Maintenance in Advanced NSCLC.
Michelsen L; Sørensen JB
Anticancer Res; 2015 Nov; 35(11):6255-9. PubMed ID: 26504059
[TBL] [Abstract][Full Text] [Related]
9. Current treatments for advanced stage non-small cell lung cancer.
Stinchcombe TE; Socinski MA
Proc Am Thorac Soc; 2009 Apr; 6(2):233-41. PubMed ID: 19349493
[TBL] [Abstract][Full Text] [Related]
10. A cost-effectiveness analysis of docetaxel versus pemetrexed in second-line chemotherapy for stage IIIb or IV non-small cell lung cancer in China.
Yu YF; Chen ZW; Zhou Z; Song ZB; Li ZM; Jian H; Zhang YF; Lu S
Chemotherapy; 2010; 56(6):472-7. PubMed ID: 21099219
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of the unresectable non small cell lung carcinoma].
Spásová I
Cas Lek Cesk; 2005; 144(9):602-12; discussion 612-3. PubMed ID: 16193938
[TBL] [Abstract][Full Text] [Related]
12. Advances in chemotherapy of non-small cell lung cancer.
Molina JR; Adjei AA; Jett JR
Chest; 2006 Oct; 130(4):1211-9. PubMed ID: 17035458
[TBL] [Abstract][Full Text] [Related]
13. Skin metastases from primary lung cancer. Report of three cases and a brief review.
Ardavanis A; Orphanos G; Ioannidis G; Rigatos G
In Vivo; 2006; 20(5):671-3. PubMed ID: 17091776
[TBL] [Abstract][Full Text] [Related]
14. Non-small cell lung cancer with distal cutaneous metastases in a patient with a previously treated colorectal carcinoma.
Thurston D; Hossain T; Waraich N; Shukla A
Ann R Coll Surg Engl; 2016 Mar; 98(3):e47-8. PubMed ID: 26890850
[TBL] [Abstract][Full Text] [Related]
15. Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis.
Hu C; Chang EL; Hassenbusch SJ; Allen PK; Woo SY; Mahajan A; Komaki R; Liao Z
Cancer; 2006 May; 106(9):1998-2004. PubMed ID: 16572401
[TBL] [Abstract][Full Text] [Related]
16. [Stage IV non small cell bronchial carcinoma; first line therapy in 2007].
Lemarié E
Rev Mal Respir; 2007 Oct; 24(8 Pt 2):6S101-7. PubMed ID: 18235401
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in non-small cell lung cancer patients who are recommended to receive single-agent chemotherapy (docetaxel or pemetrexed) as a second- or third-line chemotherapy: in the era of oncogenic drivers and molecular-targeted agents.
Shukuya T; Ko R; Mori K; Kato M; Yagishita S; Kanemaru R; Honma Y; Shibayama R; Koyama R; Shimada N; Takahashi K
Cancer Chemother Pharmacol; 2015 Oct; 76(4):771-6. PubMed ID: 26259641
[TBL] [Abstract][Full Text] [Related]
18. Erlotinib: small-molecule targeted therapy in the treatment of non-small-cell lung cancer.
Smith J
Clin Ther; 2005 Oct; 27(10):1513-34. PubMed ID: 16330289
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic chemotherapy in advanced non-small cell lung cancer: a review of standard treatment paradigms.
Socinski MA
Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4210s-4214s. PubMed ID: 15217960
[TBL] [Abstract][Full Text] [Related]
20. Erlotinib versus pemetrexed for pretreated non-squamous non-small cell lung cancer patients in clinical practice.
Zugazagoitia J; Puente J; González-Larriba JL; Manzano A; Sotelo M; Hernández S; Sanz J; Pérez P; Díaz-Rubio E
Oncology; 2013; 84(5):255-64. PubMed ID: 23428780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
